Most tumors classified as fibrosarcoma in older literature now reclassified as other entities
Must lack features of well-defined fibrosarcoma subtypes and other entities
Lacks significant nuclear pleomorphism
–
Tumors with marked pleomorphism classified as undifferentiated pleomorphic sarcoma
Clinical Issues
•
Very rare if strictly defined [except for cases arising in dermatofibrosarcoma protuberans)
•
Most arise in deep soft tissues of extremities in adults
•
Treatment: Wide surgical resection
•
Limited prognostic data using modern strict diagnostic criteria
Microscopic
•
Uniform hyperchromatic spindle cells in herringbone fascicles
•
Lacks characteristic features of other defined entities
Ancillary Tests
•
Negative for keratin, EMA, S100, desmin, most others
•
Lacks molecular signatures of other defined sarcomas
Top Differential Diagnoses
•
Fibrosarcomatous dermatofibrosarcoma protuberans
•
Undifferentiated pleomorphic sarcoma
•
Malignant peripheral nerve sheath tumor
•
Cellular dermatofibroma
•
Low-grade myofibroblastic sarcoma
TERMINOLOGY
Definitions
•
Sarcoma composed of spindle cells resembling fibroblasts
Vast majority of tumors classified as fibrosarcoma in older literature now reclassified as other entities
Currently, very rare entity, except for cases arising in dermatofibrosarcoma protuberans (DFSP)
Diagnosis should only be made with extreme caution
•
Lacks features of well-defined fibrosarcoma subtypes
•
Pleomorphic high-grade fibroblastic sarcomas are currently classified as undifferentiated pleomorphic sarcoma (PS)
CLINICAL ISSUES
Epidemiology
•
Incidence
Very rare (if strictly defined)
–
Most cases arise in DFSP in skin/superficial subcutis
•
Age
Median: 50 years
Presentation
•
Usually deep mass of lower extremity but may occur anywhere
Subset arise in subcutis
Treatment
•
Wide surgical resection